Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Two Formulations of GSK Biologicals' Varicella Vaccine Given as a 2-dose Course in the Second Year of Life

NCT00568334 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00568334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00568334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Two Formulations of GSK Biologicals' Varicella Vaccine Given as a 2-dose Course in the Second Year of Life
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
November 1, 2007
Completion date
April 29, 2008
Enrollment
244 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

varicella